Author

Seung Hyun Kim

Hanyang University Seoul HospitalORCID 0000-0001-9644-9598Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Seung Hyun Kim1 paper · University of Illinois Urbana-Champaign

Biology Disciplines

Click to filter author papers

Neuroscience· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Assay:CRISPR screen· 1 Research Focus:differential expression· 1 Assay:electronic health records· 1 Research Focus:gene regulatory network inference· 1 Approach:statistical model· 1

Frequent Co-Authors

Austin R. Ellis-MohriD· 1 shared Chang‐Seok KiiD· 1 shared Dae‐Sung KimiD· 1 shared Daniel HavertiD· 1 shared Eul Sik JungiD· 1 shared Gaurav K. UpadhyayiD· 1 shared Hayden A. Noblet· 1 shared Hee Jung ChungiD· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Austin R. Ellis-MohrORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

NeurosciencebioRxivPreprintAug 21, 2023

`Mind in Vitro' platforms: Versatile, scalable, robust and open solutions to interfacing with living neurons

Xiaotian Zhang, Zhi Wu Dou, Seung Hyun Kim…·Mattia Gazzola

The paper introduces a modular, open-source platform for interfacing with living neurons, enabling scalable and versatile recording and stimulation across various neural cultures and applications.

2 citations

electronic health recordsexperimental assay

𝕏 PostBluesky

NeurosciencebioRxivPreprintMay 4, 2022

Plasma miRNA-214 is a predictive candidate biomarker of progression speed in patients with ALS

Min‐Young Noh, Min‐Soo Kwon, Ki‐Wook Oh…·Seung Hyun Kim

This study identifies plasma miRNA-214-3p as a biomarker predicting ALS progression speed by linking it to phagocytic dysfunction in patient-derived microglia.

DOI 10.1101/2022.05.04.490596

humanstatistical model

𝕏 PostBluesky

NeurosciencebioRxivPreprintFeb 23, 2020

Successful Correction of ALD Patient-derived iPSCs Using CRISPR/Cas9

Eul Sik Jung, Zhejiu Quan, Mi‐Yoon Chang…·Hoon‐Chul Kang

This study corrects an ABCD1 mutation in ALD patient-derived iPSCs using CRISPR/Cas9 and homology-directed repair, restoring normal protein expression but not fully correcting metabolic issues.

2 citations

humanCRISPR screen

𝕏 PostBluesky